title: Growth factor modulation of fibroblast proliferation, differentiation, and invasion: implications for tissue valve engineering.
abstract: We have previously shown that transforming growth factor-beta1 (TGF-beta1) stimulates transdifferentiation of fibroblasts into smooth muscle alpha-actin (alpha-SMA) positive myofibroblasts. However, TGF-beta, as such, is unsuitable for effective population of a heart valve matrix, because it dose-dependently inhibits growth of fibroblasts. The aim of this study was to investigate combinations of other growth factors with TGF-beta to stimulate the proliferation of suitably differentiated cells and to enhance their invasion into aortic valve matrices. Human dermal mesenchymal cells (hDMC1.1) were treated with combinations of growth factors to stimulate these cells to trans-differentiate into myofibroblasts, to proliferate, and to invade. Growth factors were chosen after expression of their respective receptors was confirmed in hDMC1.1 using reverse transcriptase polymerase chain reaction. We combined TGF-beta with several growth factors such as insulin-like growth factor (IGF-1, IGF-2), epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), and platelet-derived growth factor (PDGF-AA, PDGF-BB, and PDGFAB). Nuclear Ki67 staining, MTT assay, and cell counting revealed that only EGF and bFGF were capable of overcoming TGF-beta-induced growth inhibition. However, bFGF but not EGF inhibited TGF-beta-induced alpha-SMA expression, as evidenced by immuno-cytochemistry and Western blotting. A growth factor cocktail (TGF-beta, EGF, bFGF) has been established that maintains TGF-beta-induced trans-differentiation but overcomes TGF-beta-induced growth inhibition while stimulating fibroblast proliferation and invasion.
authors.affiliation: Department of Cardiac Surgery, University Hospital Ghent, Ghent, Belgium. kishan.narine@ugent.be
authors.forename: Kishan
authors.initials: K
authors.lastname: Narine
authors.forename: Olivier
authors.initials: O
authors.lastname: De Wever
authors.forename: Dillis
authors.initials: D
authors.lastname: Van Valckenborgh
authors.forename: Katrien
authors.initials: K
authors.lastname: Francois
authors.forename: Marc
authors.initials: M
authors.lastname: Bracke
authors.forename: Stefaan
authors.initials: S
authors.lastname: DeSmet
authors.forename: Marc
authors.initials: M
authors.lastname: Mareel
authors.forename: Guido
authors.initials: G
authors.lastname: Van Nooten
mesh_terms: D001705:Bioprosthesis; D018929:Cell Culture Techniques / Q000379:methods; D002454:Cell Differentiation / Q000187:drug effects; D002465:Cell Movement / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D002478:Cells, Cultured; D005347:Fibroblasts / Q000166:cytology* / Q000187:drug effects / Q000502:physiology*; D016127:Heart Valve Prolapse; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000008:administration & dosage*; D059630:Mesenchymal Stem Cells / Q000166:cytology* / Q000187:drug effects / Q000502:physiology*; D023822:Tissue Engineering / Q000379:methods*
chemical_list: D036341:Intercellular Signaling Peptides and Proteins